Published in Bone on August 01, 2004
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Assessment of fracture risk. Osteoporos Int (2004) 5.15
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37
Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ (2011) 2.97
Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients. Osteoporos Int (2009) 2.77
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29
Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc (2013) 2.08
Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res (2008) 2.07
Appropriate osteoporosis treatment by family physicians in response to FRAX vs CAROC reporting: results from a randomized controlled trial. J Clin Densitom (2013) 2.05
Development and use of FRAX in osteoporosis. Osteoporos Int (2010) 2.04
Low bone mineral density and fracture burden in postmenopausal women. CMAJ (2007) 1.81
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int (2008) 1.68
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer. J Urol (2010) 1.66
Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev (2013) 1.63
Bone fragility contributes to the risk of fracture in children, even after moderate and severe trauma. J Bone Miner Res (2008) 1.61
Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int (2013) 1.60
Changing trends in the epidemiology of hip fracture in Spain. Osteoporos Int (2013) 1.52
Fracture Risk and Risk Factors for Osteoporosis. Dtsch Arztebl Int (2015) 1.51
The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J (2007) 1.51
Validation of a 4-item score predicting hip fracture and mortality risk among elderly women. Ann Fam Med (2007) 1.48
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int (2009) 1.47
Osteoporosis knowledge and information needs in healthcare professionals caring for patients with fragility fractures. Orthop Nurs (2007) 1.43
Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res (2010) 1.42
Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int (2010) 1.42
UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos (2017) 1.40
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int (2008) 1.39
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int (2006) 1.36
Incidence of second hip fractures. A population-based study. Osteoporos Int (2007) 1.35
A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving. Osteoporos Int (2011) 1.34
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res (2012) 1.29
The assessment of fracture risk. J Bone Joint Surg Am (2010) 1.27
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab (2013) 1.24
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int (2007) 1.22
The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int (2006) 1.22
Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int (2006) 1.18
Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int (2010) 1.18
Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord (2008) 1.16
Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int (2008) 1.15
Update in male osteoporosis. J Clin Endocrinol Metab (2010) 1.15
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ (2009) 1.12
BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int (2009) 1.12
Postfracture care for older women: gaps between optimal care and actual care. Can Fam Physician (2008) 1.11
Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J (2011) 1.11
Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int (2008) 1.11
Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns (2008) 1.09
A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int (2008) 1.09
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone (2015) 1.08
Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study. Osteoporos Int (2015) 1.07
The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study. Osteoporos Int (2005) 1.06
Influence of osteoporosis on fracture fixation--a systematic literature review. Osteoporos Int (2008) 1.06
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2007) 1.05
Breaking the fragility fracture cycle. Osteoporos Int (2011) 1.03
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int (2007) 1.03
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy. J Gen Intern Med (2009) 1.03
Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep (2010) 1.01
Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands. Osteoporos Int (2010) 1.00
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res (2009) 1.00
Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res (2011) 1.00
Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int (2011) 1.00
Closing the gap in postfracture care at the population level: a randomized controlled trial. CMAJ (2011) 1.00
The Elders Risk Assessment Index, an electronic administrative database-derived frailty index, can identify risk of hip fracture in a cohort of community-dwelling adults. Mayo Clin Proc (2012) 1.00
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial. Osteoporos Int (2007) 1.00
Determinants of fracture risk in a UK-population-based cohort of older women: a cross-sectional analysis of the Cohort for Skeletal Health in Bristol and Avon (COSHIBA). Age Ageing (2011) 0.99
Vertebral fracture assessment: impact of instrument and reader. Osteoporos Int (2009) 0.98
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol (2012) 0.97
Bone health and prostate cancer. Prostate Cancer Prostatic Dis (2009) 0.97
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials. Osteoporos Int (2006) 0.96
Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight. Osteoporos Int (2012) 0.96
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporos Int (2006) 0.96
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Osteoporos Int (2010) 0.96
Intra-and inter-reader reliability of semi-automated quantitative morphometry measurements and vertebral fracture assessment using lateral scout views from computed tomography. Osteoporos Int (2011) 0.95
The discriminatory capacity of BMD measurements by DXA and dual X-ray and laser (DXL) at the calcaneus including clinical risk factors for detecting patients with vertebral fractures. Osteoporos Int (2013) 0.95
Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int (2007) 0.94
Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int (2007) 0.94
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2010) 0.93
Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women. Osteoporos Int (2005) 0.93
Prevalence and risk factors of radiographic vertebral fractures in elderly Chinese men and women: results of Mr. OS (Hong Kong) and Ms. OS (Hong Kong) studies. Osteoporos Int (2012) 0.93
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93
A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures. Clin Orthop Relat Res (2016) 0.91
Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos Int (2012) 0.91
Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int (2008) 0.90
Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab (2006) 0.90
Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer. J Natl Compr Canc Netw (2010) 0.90
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden. Osteoporos Int (2008) 0.89
Teriparatide in the management of osteoporosis. Clin Interv Aging (2007) 0.89
Management of osteoporosis among home health and long-term care patients with a prior fracture. South Med J (2009) 0.89
The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol (2008) 0.89
Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol. J Bone Miner Metab (2013) 0.89
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Involutional osteoporosis. N Engl J Med (1986) 8.20
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Statistical methods for assessing observer variability in clinical measures. BMJ (1992) 6.24
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst (1995) 3.79
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis (2007) 3.70
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
The prevalence of chronic widespread pain in the general population. J Rheumatol (1993) 3.29
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. JAMA (1995) 3.08
Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol (1999) 3.02